Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Experts discuss how they incorporate BCMA-targeted agents into the treatment of patients with MM and manage toxicities associated with these agents. This program features ClinicalThought commentaries downloadable slides and an on-demand webcast from a live webinar.

Share

Program Content

Activities

Targeting BCMA in R/R MM
Current Strategies for Targeting BCMA in R/R Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2021

Expires: September 08, 2022

View Activity
R/R MM: Anti-BCMA Tx
FAQs on the Use of BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2021

Expires: October 28, 2022

View Activity

Activities

Anti-BCMA Tx in RR MM: Antibody–Drug Conjugates
BCMA-Targeted Antibody–Drug Conjugates in Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2021

Expires: September 09, 2022

View Activity
Anti-BCMA Tx in RR MM: CAR T-cell Therapy
BCMA-Targeted CAR T-Cell Therapy: Where Are We And Where Are We Going?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2021

Expires: September 09, 2022

View Activity
Anti-BCMA Tx in RR MM: Bispecific Antibodies
BCMA-Targeted Bispecific T-Cell Engagers and Bispecific Monoclonal Antibodies in R/R MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2021

Expires: September 09, 2022

View Activity
EP: Anti-BCMA Tx in RR MM
ExpressPoints
Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 05, 2021

Expires: October 04, 2022

View Activity

Activities

Targeting BCMA in R/R MM
Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: October 15, 2021

Expires: October 14, 2022

View Activity

Faculty

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC